The phase 3 PROOF-HD trial demonstrates persistent benefits of pridopidine on function, cognition, and motor function through the 6 month open label extension in Huntington disease (HD)
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Neurotherapeutics |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747925001527 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849765764346675200 |
|---|---|
| author | Michal Geva Ralf Reilmann Andrew Feigin Anne Rosser Sandra Kostyk Kelly Chen Yael Cohen Y Paul Goldberg Michael R. Hayden |
| author_facet | Michal Geva Ralf Reilmann Andrew Feigin Anne Rosser Sandra Kostyk Kelly Chen Yael Cohen Y Paul Goldberg Michael R. Hayden |
| author_sort | Michal Geva |
| collection | DOAJ |
| format | Article |
| id | doaj-art-de8d0f455de745088a902602e27eb5d9 |
| institution | DOAJ |
| issn | 1878-7479 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Neurotherapeutics |
| spelling | doaj-art-de8d0f455de745088a902602e27eb5d92025-08-20T03:04:46ZengElsevierNeurotherapeutics1878-74792025-07-01224e0067410.1016/j.neurot.2025.e00674The phase 3 PROOF-HD trial demonstrates persistent benefits of pridopidine on function, cognition, and motor function through the 6 month open label extension in Huntington disease (HD)Michal Geva0Ralf Reilmann1Andrew Feigin2Anne Rosser3Sandra Kostyk4Kelly Chen5Yael Cohen6Y Paul Goldberg7Michael R. Hayden8Prilenia TherapeuticsGeorge Huntington InstituteNYU Langone HealthUniversity of CardiffOhio State University College of MedicinePrilenia TherapeuticsPrilenia TherapeuticsPrilenia TherapeuticsPrilenia Therapeuticshttp://www.sciencedirect.com/science/article/pii/S1878747925001527 |
| spellingShingle | Michal Geva Ralf Reilmann Andrew Feigin Anne Rosser Sandra Kostyk Kelly Chen Yael Cohen Y Paul Goldberg Michael R. Hayden The phase 3 PROOF-HD trial demonstrates persistent benefits of pridopidine on function, cognition, and motor function through the 6 month open label extension in Huntington disease (HD) Neurotherapeutics |
| title | The phase 3 PROOF-HD trial demonstrates persistent benefits of pridopidine on function, cognition, and motor function through the 6 month open label extension in Huntington disease (HD) |
| title_full | The phase 3 PROOF-HD trial demonstrates persistent benefits of pridopidine on function, cognition, and motor function through the 6 month open label extension in Huntington disease (HD) |
| title_fullStr | The phase 3 PROOF-HD trial demonstrates persistent benefits of pridopidine on function, cognition, and motor function through the 6 month open label extension in Huntington disease (HD) |
| title_full_unstemmed | The phase 3 PROOF-HD trial demonstrates persistent benefits of pridopidine on function, cognition, and motor function through the 6 month open label extension in Huntington disease (HD) |
| title_short | The phase 3 PROOF-HD trial demonstrates persistent benefits of pridopidine on function, cognition, and motor function through the 6 month open label extension in Huntington disease (HD) |
| title_sort | phase 3 proof hd trial demonstrates persistent benefits of pridopidine on function cognition and motor function through the 6 month open label extension in huntington disease hd |
| url | http://www.sciencedirect.com/science/article/pii/S1878747925001527 |
| work_keys_str_mv | AT michalgeva thephase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT ralfreilmann thephase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT andrewfeigin thephase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT annerosser thephase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT sandrakostyk thephase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT kellychen thephase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT yaelcohen thephase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT ypaulgoldberg thephase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT michaelrhayden thephase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT michalgeva phase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT ralfreilmann phase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT andrewfeigin phase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT annerosser phase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT sandrakostyk phase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT kellychen phase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT yaelcohen phase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT ypaulgoldberg phase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd AT michaelrhayden phase3proofhdtrialdemonstratespersistentbenefitsofpridopidineonfunctioncognitionandmotorfunctionthroughthe6monthopenlabelextensioninhuntingtondiseasehd |